Inhibition of hepatitis C virus infection and expression <i>in vitro</i> and <i>in vivo</i> by recombinant adenovirus expressing short hairpin RNA

Taken together, our results support the feasibility of utilizing gene targeting therapy based on siRNA and/or shRNA expression to counteract HCV replication, which might prove valuable in the treatment of hepatitis C.